ADAP - Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q4 2019 Results - Earnings Call Transcript
Adaptimmune Therapeutics plc (ADAP)
Q4 2019 Earnings Conference Call
February 27, 2020 8:00 AM ET
Company Participants
Juli Miller - Director of Investor Relations
Adrian Rawcliffe - Chief Executive Officer
Helen Tayton-Martin - Chief Business Officer
Elliot Norry - Chief Medical Officer
Conference Call Participants
Tony Butler - Roth Capital
Marc Frahm - Cowen and Company
Kelsey Goodwin - Guggenheim Securities
James Shannon - Citi
Jonathan Chang - SVB Leerink
Presentation
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the Fourth Quarter and Full Year 2019 Adaptimmune Earnings Conference Call. At